Quantitative imaging reveals steatosis and fibro-inflammation in multiple organs in people with type 2 diabetes: a real-world study

The first comprehensive analysis of multi-organ steatosis and fibro-inflammation in people living with obesity and type 2 diabetes receiving routine hospital care. Those on weight loss treatments saw improvements in organ health that did not occur in patients on metformin, highlighting the measurable and visible impact of weight-loss therapies in real-world patients.